Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution

SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several studies in this issue of Cancer Cell add to our knowledge of the heterogeneity of immune responses to vaccination among patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffiths, Elizabeth A., Segal, Brahm H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253695/
https://www.ncbi.nlm.nih.gov/pubmed/34242573
http://dx.doi.org/10.1016/j.ccell.2021.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253695/
https://www.ncbi.nlm.nih.gov/pubmed/34242573
http://dx.doi.org/10.1016/j.ccell.2021.07.001

Ejemplares similares